Hepatitis B Infection Clinical Trial
Official title:
A Randomized, Open-label, Single-center, Phase II Trial to Explore the Safety and Efficacy of GC1102 and Determine Its Optimal Dose After Intravenous Administration in HBV-related Liver Transplant Recipients
This is a proof-of-concept study for GC1102 to demonstrate preventing the recurrence of hepatitis B virus (HBV) infection following liver transplantation and a dose-finding study to determine its optional dose.
GC1102 is a new recombinant hepatitis B immunoglobulin (HBIg) from Chinese Hamster Ovary (CHO) cells. It is a monoclonal antibody and has high affinity and avidity to hepatitis B surface antigen and several advantages compared to HBIg derived from blood plasma of human donors. Forty volunteers will participate in the study, receive 24-week treatment with low dose (50,000IU) of GC1102 or with high dose (80,000IU) and be followed up till 28 weeks. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04704024 -
Reducing Vertical Transmission of Hepatitis B in Africa
|
Phase 3 | |
| Active, not recruiting |
NCT02143401 -
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
|
Phase 1 | |
| Completed |
NCT00371150 -
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection
|
Phase 4 | |
| Active, not recruiting |
NCT03519113 -
HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102
|
Phase 2/Phase 3 | |
| Completed |
NCT01788371 -
Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus
|
Phase 4 | |
| Recruiting |
NCT06368479 -
Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site Settings
|
N/A | |
| Completed |
NCT01488526 -
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
|
Phase 4 | |
| Terminated |
NCT02826018 -
A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection
|
Phase 1 | |
| Completed |
NCT01970254 -
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy
|
||
| Completed |
NCT00489099 -
A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)
|
Phase 3 | |
| Recruiting |
NCT03476083 -
Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission
|
Phase 4 | |
| Recruiting |
NCT03865966 -
Hepatitis B Virus Infection After Liver Transplantation in Children
|
||
| Completed |
NCT03627507 -
Non Inferiority Trial of Locally Manufactured 'Hepa-B' Vaccine in Bangladesh.
|
Phase 2/Phase 3 | |
| Completed |
NCT02443233 -
Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong
|
N/A | |
| Completed |
NCT00841477 -
An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users
|
Phase 3 | |
| Terminated |
NCT03887702 -
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
|
Phase 3 | |
| Active, not recruiting |
NCT05117541 -
Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection
|
||
| Not yet recruiting |
NCT06368466 -
A Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Sites
|
N/A |